Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Journal of the American College of Nutrition

Volumn 34, Issue 6, 2015, Pages 459-469

  Spaiser, Samuel J ^a   Culpepper, Tyler ^a   Nieves, Carmelo ^a   Ukhanova, Maria ^b   Mai, Volker ^b   Percival, Susan S ^a   Christman, Mary C ^c,d   Langkamp Henken, Bobbi ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c University of Florida   (United States)

^d MCC Statistical Consulting   (United States)

Author keywords

Bifidobacterium bifidum G9 1; Bifidobacterium longum MM 2; cytokines; gastrointestinal function; gut microbiota; immune function; inflammation; Lactobacillus gasseri KS 13; older adults; probiotics

Indexed keywords

BIFIDOBACTERIUM BIFIDUM G9 1 EXTRACT; BIFIDOBACTERIUM LONGUM MM 2 EXTRACT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5; LACTOBACILLUS GASSERI KS 13 EXTRACT; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG; CYTOKINE;

AGED; ALLERGY; ARTICLE; BIFIDOBACTERIUM BIFIDUM; BLOOD SAMPLING; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; COLITIS; COMMON COLD SYMPTOM; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOKINE PRODUCTION; DNA EXTRACTION; DOUBLE BLIND PROCEDURE; ESCHERICHIA COLI; FAECALIBACTERIUM PRAUSNITZII; FATIGUE; FECES ANALYSIS; FEMALE; GASTROINTESTINAL TRACT FUNCTION; HEART ATRIUM FLUTTER; HUMAN; IMMUNITY; INTESTINE FLORA; LACTOBACILLUS GASSERI; MALE; NONHUMAN; PYROSEQUENCING; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; TINNITUS; AGING; BACTERIAL LOAD; BIFIDOBACTERIUM; BLOOD; CD4 LYMPHOCYTE COUNT; CLASSIFICATION; FECES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; IMMUNOLOGY; INFLAMMATION; LACTOBACILLUS; MICROBIOLOGY; PHYSIOLOGY;

AGED; AGING; BACTERIAL LOAD; BIFIDOBACTERIUM; CD4 LYMPHOCYTE COUNT; CROSS-OVER STUDIES; CYTOKINES; DOUBLE-BLIND METHOD; FECES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; LACTOBACILLUS; PLACEBOS; PROBIOTICS; SURVEYS AND QUESTIONNAIRES;

EID: 84944162251     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2014.983249     Document Type: Article

References (52)

1. L.Nagelkerken, A.Hertogh-Huijbregts, R.Dobber, A.Dräger: Age-related changes in lymphokine production related to a decreased number of CD45RBhi CD4 + T cells. Eur J Immunol 21:273–281, 1991.
2. L.Haynes, P.J.Linton, S.M.Eaton, S.L.Tonkonogy, S.L.Swain: Interleukin 2, but not other common gamma chain–binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med 190:1013–1024, 1999.
3. C.Jackaman, D.E.Dye, D.J.Nelson: IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice. Age 36:1315-1328, 2014.
4. J.E.Callahan, J.W.Kappler, P.Marrack: Unexpected expansions of CD8-bearing cells in old mice. J Immunol 151:6657–6669, 1993.
5. R.A.Miller: Age-related changes in T cell surface markers: a longitudinal analysis in genetically heterogeneous mice. Mech Ageing Dev 96:181–196, 1997.
6. S.Alberti, E.Cevenini, R.Ostan, M.Capri, S.Salvioli, L.Bucci, L.Ginaldi, M.De Martinis, C.Franceschi, D.Monti: Age-dependent modifications of type 1 and type 2 cytokines within virgin and memory CD4+ T cells in humans. Mech Ageing Dev 127:560–566, 2006.
7. T.Milner, L.Reilly, N.Nausch, N.Midzi, T.Mduluza, R.Maizels, F.Mutapi: Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status. Parasite Immunol 32:710–721, 2010.
8. M.J.Hopkins, G.T.Macfarlane: Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51:448–454, 2002.
9. M.J.Hopkins, R.Sharp, G.T.Macfarlane: Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48:198–205, 2001.
10. B.Kleessen, B.Sykura, H.J.Zunft, M.Blaut: Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 65:1397–1402, 1997.
11. Y.Kotani, S.Shinkai, H.Okamatsu, M.Toba, K.Ogawa, H.Yoshida, T.Fukaya, Y.Fujiwara, P.H.Chaves, K.Kakumoto, N.Kohda: Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: a randomized, placebo-controlled, double-blind trial. Immun Ageing 7:1-11, 2010.
12. Y.Sjögren, S.Tomicic, A.Lundberg, M.Böttcher, B.Björkstén, E.Sverremark-Ekström, M.Jenmalm: Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy 39:1842–1851, 2009.
13. K.Kato, S.Mizuno, Y.Umesaki, Y.Ishii, M.Sugitani, A.Imaoka, M.Otsuka, O.Hasunuma, R.Kurihara, A.Iwasaki, Y.Arakawa: Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 20:1133–1141, 2004.
14. H.S.Gill, K.J.Rutherfurd, M.L.Cross, P.K.Gopal: Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74:833–839, 2001.
15. S.Sierra, F.Lara-Villoslada, L.Sempere, M.Olivares, J.Boza, J.Xaus: Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults. Anaerobe 16:195–200, 2010.
16. J.E.Everhart, V.L.Go, R.S.Johannes, S.C.Fitzsimmons, H.P.Roth, L.R.White: A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 34:1153–1162, 1989.
17. J.Zwielehner, K.Liszt, M.Handschur, C.Lassl, A.Lapin, A.G.Haslberger: Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp Gerontol 44:440–446, 2009.
18. E.Biagi, L.Nylund, M.Candela, R.Ostan, L.Bucci, E.Pini, J.Nikkïla, D.Monti, R.Satokari, C.Franceschi, P.Brigidi, W.De Vos: Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5:e10667, 2010.
19. C.Gomez-Llorente, J.Plaza-Diaz, M.Aguilera, S.Muñoz-Quezada, M.Bermudez-Brito, P.Peso-Echarri, R.Martinez-Silla, M.I.Vasallo-Morillas, L.Campaña-Martin, I.Vives-Piñera, M.J.Ballesta-Martinez, A.Gil: Three main factors define changes in fecal microbiota associated with feeding modality in infants. J Pediatr Gastr Nutr 57:461–466, 2013.
20. H.Akatsu, N.Iwabuchi, J.Z.Xiao, Z.Matsuyama, R.Kurihara, K.Okuda, T.Yamamoto, M.Maruyama: Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding. JPEN J Parenter Enteral Nutr 37:631–640, 2012.
21. J.Kondo, J.Z.Xiao, A.Shirahata, M.Baba, A.Abe, K.Ogawa, T.Shimoda: Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding. World J Gastroenterol 19:2162–2170, 2013.
22. S.Rampelli, M.Candela, M.Severgnini, E.Biagi, S.Turroni, M.Roselli, P.Carnevali, L.Donini, P.Brigidi: A probiotics-containing biscuit modulates the intestinal microbiota in the elderly. J Nutr Health Aging 17:166–172, 2013.
23. M.J.Claesson, S.Cusack, O.O'Sullivan, R.Greene-Diniz, H.de Weerd, E.Flannery, J.R.Marchesi, D.Falush, T.Dinan, G.Fitzgerald, C.Stanton, D.van Sinderen, M.O’Connor, N.Harnedy, K.O’Connor, C.Henry, D.O’Mahony, A.P.Fitzgerald, F.Shanahan, C.Twomey, C.Hill, R.P.Ross, P.W.O'Toole: Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 108(Suppl 1):4586–4591, 2011.
24. H.Sokol, P.Seksik, L.Rigottier-Gois, C.Lay, P.Lepage, I.Podglajen, P.Marteau, J.Doré: Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12:106–111, 2006.
25. C.Manichanh, L.Rigottier-Gois, E.Bonnaud, K.Gloux, E.Pelletier, L.Frangeul, R.Nalin, C.Jarrin, P.Chardon, P.Marteau, J.Roca, J.Dore: Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55:205–211, 2006.
26. M.Candela, C.Consolandi, M.Severgnini, E.Biagi, B.Castiglioni, B.Vitali, G.De Bellis, P.Brigidi: High taxonomic level fingerprint of the human intestinal microbiota by ligase detection reaction—universal array approach. BMC Microbiol 10:1-16, 2010.
27. Y.Guigoz, B.Vellas, P.J.Garry: Assessing the nutritional status of the elderly: the Mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev 54:S59–S65, 1996.
28. B.Vellas, Y.Guigoz, P.J.Garry, F.Nourhashemi, D.Bennahum, S.Lauque, J.L.Albarede: The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 15:116–122, 1999.
29. B.Langkamp-Henken, C.Nieves, T.Culpepper, A.Radford, S.A.Girard, C.Hughes, M.C.Christman, V.Mai, W.J.Dahl, T.Boileau, S.S.Jonnalagadda, F.Thielecke: Fecal lactic acid bacteria increased in adolescents randomized to whole-grain but not refined-grain foods, whereas inflammatory cytokine production decreased equally with both interventions. J Nutr 142:2025–2032, 2012.
30. S.J.Lewis, K.W.Heaton: Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 32:920–924, 1997.
31. D.A.Revicki, M.Wood, I.Wiklund, J.Crawley: Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 7:75–83, 1998.
32. M.L.Cross, R.R.Mortensen, J.Kudsk, H.S.Gill: Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice. Med Microbiol Immunol 191:49–53, 2002.
33. H.Dong, I.Rowland, P.Yaqoob: Comparative effects of six probiotic strains on immune function in vitro. Br J Nutr 108:459–470, 2012.
34. M.Olivares, M.P.Díaz-Ropero, N.Gómez, F.Lara-Villoslada, S.Sierra, J.A.Maldonado, R.Martín, J.M.Rodríguez, J.Xaus: The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol 9:47–52, 2006.
35. R.A.Kekkonen, E.Kajasto, M.Miettinen, V.Veckman, R.Korpela, I.Julkunen: Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. World J Gastroenterol 14:1192–1203, 2008.
36. R.Kaji, J.Kiyoshima-Shibata, M.Nagaoka, M.Nanno, K.Shida: Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 184:3505–3513, 2010.
37. W.J.Chng, G.B.Tan, P.Kuperan: Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies. Clin Diagn Lab Immunol 11:168–173, 2004.
38. J.W.Navalta, S.Lyons, J.Prestes, S.W.Arnett, M.Schafer, G.L.Sobrero: Exercise intensity and lymphocyte subset apoptosis. Int J Sports Med 34:268–273, 2013.
39. U.A.Walker, K.Warnatz: Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol 18:389–395, 2006.
40. A.J.Torres, A.L.Angelo, E.M.Netto, G.P.Sampaio, D.F.Souza, L.A.Inocencio, J.A.Lemos, C.Brites: Reference range for T lymphocytes populations in blood donors from two different regions in Brazil. Braz J Infect Dis 13:221–225, 2009.
41. C.P.de Jager, E.F.Gemen, J.Leuvenink, M.Hilbink, R.J.Laheij, T.van der Poll, P.C.Wever: Dynamics of peripheral blood lymphocyte subpopulations in the acute and subacute phase of Legionnaires’ disease. PLoS One 8:e62265, 2013.
42. A.Darfeuille-Michaud, J.Boudeau, P.Bulois, C.Neut, A.L.Glasser, N.Barnich, M.A.Bringer, A.Swidsinski, L.Beaugerie, J.F.Colombel: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127:412–421, 2004.
43. M.Martinez-Medina, X.Aldeguer, M.Lopez-Siles, F.González-Huix, C.López-Oliu, G.Dahbi, J.E.Blanco, J.Blanco, L.J.Garcia-Gil, A.Darfeuille-Michaud: Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis 15:872–882, 2009.
44. H.Sokol, B.Pigneur, L.Watterlot, O.Lakhdari, L.G.Bermúdez-Humarán, J.J.Gratadoux, S.Blugeon, C.Bridonneau, J.P.Furet, G.Corthier, C.Grangette, N.Vasquez, P.Pochart, G.Trugnan, G.Thomas, H.M.Blottière, J.Doré, P.Marteau, P.Seksik, P.Langella: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105:16731–16736, 2008.
45. D.N.Frank, A.L.St Amand, R.A.Feldman, E.C.Boedeker, N.Harpaz, N.R.Pace: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 104:13780–13785, 2007.
46. T.Fujimoto, H.Imaeda, K.Takahashi, E.Kasumi, S.Bamba, Y.Fujiyama, A.Andoh: Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol 28:613–619, 2013.
47. S.Bartosch, A.Fite, G.T.Macfarlane, M.E.McMurdo: Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70:3575–3581, 2004.
48. S.Mueller, K.Saunier, C.Hanisch, E.Norin, L.Alm, T.Midtvedt, A.Cresci, S.Silvi, C.Orpianesi, M.C.Verdenelli, T.Clavel, C.Koebnick, H.J.Zunft, J.Doré, M.Blaut: Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72:1027–1033, 2006.
49. Y.Kotani, J.Kunisawa, Y.Suzuki, I.Sato, T.Saito, M.Toba, N.Kohda, H.Kiyono: Role of Lactobacillus pentosus strain b240 and the toll-like receptor 2 axis in Peyer's patch dendritic cell-mediated immunoglobulin A enhancement. PLoS One 9:e91857, 2014.
50. J.Kunisawa, H.Kiyono: A marvel of mucosal T cells and secretory antibodies for the creation of first lines of defense. Cell Mol Life Sci 62:1308–1321, 2005.
51. Centers for Disease Control and Prevention: FluView: National and Regional Level Outpatient Illness and Viral Surveillance. 2014. Accessed at: http://gis.cdc.gov/grasp/fluview/fluportaldashboard.html
52. Received July 17, 2014; Accepted October 28, 2014.